Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study

Archives of Internal Medicine

Volumn 159, Issue 18, 1999, Pages 2151-2159

  Kao, W H Linda ^a   Folsom, Aaron R ^c   Nieto, F Javier ^a   Mo, Jing Ping ^d   Watson, Robert L ^e   Brancati, Frederick L ^a,b,f  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d IL   (United States)

^e UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; MAGNESIUM;

ADULT; ARTICLE; COHORT ANALYSIS; DIET RESTRICTION; FEMALE; HUMAN; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; HUMANS; INCIDENCE; INSULIN; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 0033547207     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.18.2151     Document Type: Article

References (52)

1. Geiss LS, Herman WH, Smith PJ. Mortality in NIDDM. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health; 1995:236-249.
2. American Diabetes Association. The dangerous toll of diabetes [American Diabetes Association Web site]. 1997. Available at: http://www.diabetes.org/ada /c20f.asp. Accessed October 5, 1998.
3. Haffner SM. Risk factors for non-insulin-dependent diabetes mellitus. J Hypertens Suppl. 1995;13(suppl):S73-S76.
4. DeFronzo RA. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetotogia. 1992;35:389-397.
5. Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. BMJ. 1984;288:1032-1034.
6. Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:767-770.
7. Paolisso G, Ravussin E. Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab. 1995;80:1382-1385.
8. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511-514.
9. Levin GE, Mather HM, Pilkington TR. Tissue magnesium status in diabetes mellitus. Diabetologia. 1981;21:131-134.
10. Alzaid AA, Dinneen SF, Moyer TP, Rizza RA. Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J Clin Endocrinol Metab. 1995;80:1376-1381.
11. McNair P, Christensen MS, Christiansen C, Madsbad S, Transbol I. Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis. Eur J Clin Invest. 1982;12:81-85.
12. Mather HM, Nisbet JA, Burton GH, et al. Hypomagnesaemia in diabetes. Clin Chim Acta 1979;95:235-242.
13. White JR Jr, Campbell RK. Magnesium and diabetes: a review Ann Pharmacother. 1993;27:775-780.
14. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. J Clin Epidemiol. 1995;48:927-940.
15. Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab. 1993;76:549-553.
16. Gueux E, Rayssiguier Y. The effect of magnesium deficiency on glucose stimulated insulin secretion in rats. Horm Metab Res. 1983;15:594-597.
17. Balon TW, Gu JL, Tokuyama Y, Jasman AP, Nadler JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol. 1995;269(pt 1):E745-E752.
18. Paolisso G, Sgambato S, Gambardella A, et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 1992;55:1161-1167.
19. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care. 1989;12:265-269.
20. Paolisso G, Scheen A, Cozzolino D, et al. Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab. 1994;78:1510-1514.
21. Paolisso G, Passariello N, Pizza G, et al. Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. Acta Endocrinol (Copenh). 1989;121:16-20.
22. Paolisso G, Sgambato S, Giugliano D, et al. Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1988;31:910-915.
23. Lowenstein FW, Stanton MF. Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr. 1986;5:399-414.
24. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129:687-702.
25. National Heart, Lung, and Blood Institute Atherosclerosis Risk in Communities ARIC Study. Operations Manual No. 7: Blood Collection and Processing. Bethesda, Md, National Heart, Lung, and Blood Institute; 1987.
26. Gindler EM, Heth DA. Colorimetric determination with bound "Calmagite" of magnesium in human blood serum [abstract]. Clin Chem. 1971;17:662.
27. Centers for Disease Control and Prevention. National Glucose Reference Method. Bethesda, Md: US Dept of Health Education, and Welfare; 1976. Publication CDC 77-8330.
28. Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. Am J Clin Pathol. 1966;45:290-296.
29. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36: 936-942.
30. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol. 1988;127:188-199.
31. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semi-quantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
32. Elin RJ. Magnesium metabolism in health and disease. Dis Mon. 1988;34:161-218.
33. SAS Institute, Inc. SAS User's Guide: Statistics, Version 6.11. Cary, NC: SAS Institute Inc; 1989.
34. Djurhuus MS, Skott P, Hother-Nielson O, Klitgaard NA, Beck-Nielsen H. Insulin increases renal magnesium excretion: a possible cause of magnesium depletion in hyperinsulinaemic states. Diabet Med. 1995;12:664-669.
35. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension. 1991;17(pt 2):951-957.
36. Mather HM, Levin GE, Nisbet JA, Hadley LA, Oakley NW, Pilkington TR. Diurnal profiles of plasma magnesium and blood glucose in diabetes. Diabetologia. 1982; 22:180-183.
37. Elin RJ. Assessment of magnesium status. Clin Chem. 1987;33:1965-1970.
38. Djurhuus MS, Gram J, Petersen PH, Klitgaard NA, Bollerslev J, Beck-Nielsen H. Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest. 1995;55:549-558.
39. Ryzen E, Servis KL, DeRusso P, Kershaw A, Stephen T, Rude RK. Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. J Am Coll Nutr. 1989;8:580-587.
40. Hanson RL, Nelson RG, McCance DR, et al. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med. 1993;153:2133-2140.
41. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183.
42. Mooy JM, Grootenhuis PA, deVries H, Kostense PJ, Popp-Snijders C, Bouter LM. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia. 1996;39:298-305.
43. Wacker WE. The biochemistry of magnesium. Ann N Y Acad Sci. 1969;162:717-726.
44. Stryer L. Biochemistry. 3rd ed. New York, NY: WH Freeman & Co; 1988.
45. Somlyo AV, Woo CY, Somlyo AP. Effect of magnesium on posterior pituitary hormone action on vascular smooth muscle. Am J Physiol. 1966;210:705-714.
46. Tongyai S, Rayssiguier Y, Motta C, Gueux E, Maurois P, Heaton FW. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol. 1989;257(pt 1):C270-C276.
47. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL. Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res. 1995; 27:19-22.
48. Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990;39:647-652.
49. Barbagallo M, Gupta RK, Resnick LM. Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study. Diabetologia. 1993; 36:146-149.
50. Paolisso G, Sgambato S, Passariello N, et al. Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia. 1986;29:644-647.
51. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr. 1992;55:1018-1023.
52. Rasmussen HS, Cintin C, Aurup P, Breum L, McNair P. The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction. Arch Intern Med. 1988;148:1801-1805.